Resultados de la búsqueda 451-460 of 9599 for Dupuytren’s contracture
This drug combination is still experimental and is not approved by the FDA. Discontinuation of pirtobrutinib and venetoclax based on minimal residual disease ( ...
... disease cohort, both across and within tumor biomarker subgroups. A Study to Evaluate DS-8201a Combined with Olaparib in HER2-Expressing Cancers with ...
Detection of Vascular and Inflammatory Plasma Biomarkers in Patients Diagnosed with Obstructive Sleep Apnea and MRI-defined Cerebral Small Vessel Disease.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?
Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these ...
The purpose of this study is to collect clinical information, blood and tissue samples from people with Crohn's disease at the time of their bowel resection ...
... disease subtypes that predict response to individual treatments, combinations, or sequences. ... disease becomes tumor permissive. A Study of Women ...
Jacksonville, Fla. The primary purpose of this study is to create a Mayo Clinic repository for neurodegenerative disorders such as Parkinson's disease (PD), ...
... disease ranges for each analyte measured and to improve the care of these patients by reducing the number of false positive results and unnecessary follow-up.
... disease progression and treatment response. Pertuzumab, Trastuzumab ... The purpose of this study is to identify a biomarker (or biomarkers) that is present when ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.